Showing 1 - 2 results of 2 for search 'Paul J. Adam', query time: 0.02s
Refine Results
-
1
-
2
LY6G6D is a selectively expressed colorectal cancer antigen that can be used for targeting a therapeutic T-cell response by a T-cell engager by Leticia Corrales, Susanne Hipp, Susanne Hipp, Katharina Martin, Nicolas Sabarth, Iñigo Tirapu, Klaus Fuchs, Barbara Thaler, Christian Walterskirchen, Kathrin Bauer, Markus Fabits, Michael Bergmann, Carina Binder, Paolo ML. Chetta, Anne B. Vogt, Paul J. Adam
Published 2022-09-01
Article